Since 2014, Treatment Action Group’s website has featured a regularly updated listing of clinical trials and observational studies related to the scientific effort to develop a cure for HIV infection. Clinical trials typically involve the administration of experimental interventions, whereas observational studies only require blood draws or other sampling.
On February 9, TAG submitted this testimony to the Office of the High Commission for Human Rights (OHCHR) to inform its upcoming report to the Human Rights Council (HRC) on 'human rights in the context of HIV/AIDS' (HRC resolution 47/17).
Engagement of affected communities in research is vital to ensuring that the science is ethical and responsive to community priorities and needs. This module covers the history of community-based HIV research advocacy and outlines principles and best practices for community…
Some HIV cure research studies ask participants to temporarily stop antiretroviral therapy, which is referred to as an analytical treatment interruption (ATI). This module explains the use of ATIs in HIV cure research and covers what is currently known about…
An overview of current knowledge regarding how HIV persists in the body despite suppression of viral load by antiretroviral therapy. Understanding the mechanisms by which HIV persists is considered key to developing curative interventions that would prevent the virus rebounding…
Scientists are pursuing multiple approaches with the aim of developing interventions capable of curing HIV or keeping HIV durably suppressed in the absence of antiretroviral therapy. This module provides an overview of the many strategies that are currently under investigation…
Ethics are a cornerstone of all scientific research, providing principles by which studies should be conducted to ensure that participants are properly informed and that any risks are justified and acceptable. This module provides background on research ethics and covers…
An introductory overview of the research effort to develop a cure for HIV infection. Topics covered include terms and definitions used in HIV cure research, the reasons why a cure is needed, evidence supporting that a cure is possible, and…
Treatment Action Group (TAG) welcomes and celebrates the U.S. Food and Drug Administration’s (FDA) approval of Apretude brand cabotegravir, the first injectable medication for use as pre-exposure prophylaxis (PrEP) to reduce the risk of HIV transmission.
As we look forward to an end of an extremely challenging year—and past four years—we reflect on the remarkable resilience and impact of TAG, even and especially in these dark times.
Your donation will bring progress, healing, and hope — turning the promise of innovative research into a brighter, healthier future for all.
